Provided by Tiger Trade Technology Pte. Ltd.

Merck

148.46
-1.8700-1.24%
Post-market: 148.28-0.1841-0.12%18:14 EDT
Volume:11.19M
Turnover:1.66B
Market Cap:366.28B
PE:116.64
High:149.60
Open:148.41
Low:146.28
Close:150.33
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.37
T/O Rate:0.45%
Dividend:3.32
Dividend Rate:2.24%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.73
PE(LYR):20.39

Loading ...

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Moderna Led the S&P 500 in August as Edison International Sank

Dow Jones
·
Sep 01

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28

RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
Aug 27

Nike, Merck Share Losses Contribute to Dow's 150-Point Drop

Dow Jones
·
Aug 26

Merck & Co. Inc. Stock Rises 3.8%, Outperforms Peers

Dow Jones
·
Aug 26

Dow up 136 Points on Gains for Shares of Merck, Goldman Sachs

Dow Jones
·
Aug 26

Merck & Co Inc Stock (MRK) Moved Up by 3.76% on Aug 25: A Full Analysis

TradingKey
·
Aug 26

Movement Alert|Merck Rises 3.06% in Regular Trading, Multiple Analyst Upgrades Continue to Boost Shares Following mRNA Cancer Vaccine Phase III Success

Market Focus
·
Aug 26

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

Merck Price Target Raised to $170.00/Share from $145.00 by Argus Research

Dow Jones
·
Aug 25

Merck & Company (MRK) Gets a Buy from Scotiabank

TIPRANKS
·
Aug 25

Merck price target raised to $170 from $145 at Argus

TIPRANKS
·
Aug 25

Merck price target raised to $180 from $155 at Wolfe Research

TIPRANKS
·
Aug 25

Merck (MRK) Stock May Be 35% Undervalued After Cancer Vaccine Data

Simply Wall St.
·
Aug 25

Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.

Dow Jones
·
Aug 24

Barclays Raises Moderna PT on 'transformative' Melanoma Vaccine Potential

Reuters
·
Aug 24

BUZZ-US Stocks Weekly: Rate Rattle

Reuters
·
Aug 24

Celltrion Seeks Korean Approval for Keytruda Biosimilar CT-P51 After Positive Trial

TIPRANKS
·
Aug 24